MOSAIC Mobile Program for Type 2 Diabetes
(MOSAIC Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, since participants must be prescribed at least one daily diabetes medication, it seems likely that you can continue your current diabetes treatment.
What data supports the effectiveness of the MOSAIC treatment for Type 2 Diabetes?
Research shows that digital health coaching and mobile health interventions, similar to the MOSAIC treatment, can improve diabetes management. For example, a study found that a digital health coaching program significantly improved insulin resistance in people with Type 2 Diabetes, suggesting that mobile programs can effectively support lifestyle and medication adherence.12345
Is the MOSAIC Mobile Program for Type 2 Diabetes safe for humans?
How is the MOSAIC treatment for Type 2 Diabetes different from other treatments?
The MOSAIC treatment is unique because it uses a mobile app enhanced with virtual coaching to provide personalized, real-time support for managing Type 2 Diabetes. This approach helps overcome common treatment barriers and improves engagement and satisfaction compared to traditional methods.510111213
What is the purpose of this trial?
This behavioral clinical trial evaluates an adaptively tailored, mobile phone-delivered intervention (MOSAIC) designed to support adults managing their type 2 diabetes. Adaptive means the intervention can change over time. Tailored means the intervention may be different for different participants. The main questions the study will aim to answer are:1. Does the diabetes education and support delivered via the MOSAIC adaptive mobile phone-delivered intervention improve outcomes more than diabetes education and support delivered via print materials alone? This aim compares the study arms on outcomes such as glycemic management (hemoglobin A1c), diabetes distress, and psychosocial well-being. This aim also compares the study arms on intervention targets (mediators) including diabetes self-efficacy and self-care behaviors.2. For whom does the MOSAIC adaptive tailoring approach improve outcomes more than the print materials alone? This aim examines how well the tailoring rules used for the MOSAIC intervention worked for different participants on the outcomes examined in the first aim.Participants will enroll in a 16-month study with assessments every 4 months. Assessments include completion of an A1c test and a survey. For those assigned to MOSAIC, they will experience 12-months of mobile phone-delivered support with 3 opportunities for intervention tailoring.
Eligibility Criteria
This trial is for adults with type 2 diabetes who are interested in managing their condition. Participants will be involved in a 16-month study, but specific inclusion and exclusion criteria details are not provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the MOSAIC mobile phone-delivered intervention or print materials for 12 months
Follow-up
Participants are monitored for sustained effects on glycemic management and psychosocial well-being
Treatment Details
Interventions
- MOSAIC
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanderbilt University Medical Center
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
University of Alabama at Birmingham
Collaborator